TRK-170

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTRK-170
Drug Alias NameTRK-170
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 antagonists
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[13] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesToray Industries Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToray Industries Inc
Active IndicationsN/A
Inactive IndicationsCrohn Disease

Other Information

ATC CodeN/A
Related LinksN/A